White I N
Chem Biol Interact. 1977 Feb;16(2):169-80. doi: 10.1016/0009-2797(77)90126-0.
(1) A comparison has been made in male rats between the biliary excretion of pyrrolic metabolites from the pyrrolizidine alkaloid retrorsine and a synthetic analogue 1-methyl-2,3-pyrroline-bis-N-ethyl-carbamate (Synthanecine A bis-N-ethylcarbamate). (2) When bile duct-cannulated rats were given retrorsine (40 mg/kg) and the bile collected at 1 h intervals, the relative concentration of pyrrolic metabolites was greatest in the first 1 h sample and was negligibly small by 7 h after dosing. By 7 h, about 25% of the dose had been excreted as pyrrolic metabolites. (3) In rats given [3H]synthanecine A bis-N-ethylcarbamate (40 mg/kg), the amounts of radioactivity and the relative levels of pyrrolic metabolites in the bile were greatest in the first 0.5 h sample and became negligibly small by 4 h after dosing. Within this time, about 25% of the dose had been excreted as [3H]radioactivity in the bile only about 5% as pyrrolic metabolites. (4) When rats were given [3H]2,3-bishydroxymethyl-1-methyl pyrrole (10 mg/kg), a proposed pyrrolic metabolite of synthanecine A bis-N-ethylcarbamate, about 17% of the dose was excreted for as [3H]radioactivity in the bile but only about 3% could be accounted for as pyrrolic metabolites. (5) Thin-layer chromatography of bile from rats given [3H]2,3-bishydroxy-methyl-1-methylpyrrole or [3H]synthanecine A bis-N-ethylcarbamate showed little redioactivity or Ehrlich-positive pyrrolic metabolites with an RF value corresponding to that of 2,3-bishydroxymethyl-1-methylpyrrole. A large proportion of the radioactivity label and most of the Ehrlich positive pyrrolic metabolites were associated with highly polar derivatives at the origin of the TLC plate. (6) It was concluded that biliary excretion plays an important role in the disposal of metabolites from both retrorsine and synthanecine A bis-N-ethyl-carbamate though not for the parent compounds. The expected hydroxy-methyl pyrrolic metabolites undergo further modification to more polar derivatives. In the case of retrorsine, these retained their abilities to react with Ehrlich reagent, while with pyrrolic metabolites from synthanecine A bis-N-ethylcarbamate, substatial conversion to Ehrlich negative derivatives occurred. (7) When bile of rats given [3H]synthanecine A bis-N-ethylcarbamate was injected intraduodenally into recipient animals, reabsorbtion of the radioactive label accounted for less than 4% of the dose given to the donor animals, indicating the enterohepatic circulation is probably only of minor importance influencing the elimination of these compounds.
(1) 已对雄性大鼠中来自吡咯里西啶生物碱倒千里光碱的吡咯代谢物与合成类似物1-甲基-2,3-吡咯啉-双-N-乙基氨基甲酸酯(Synthanecine A双-N-乙基氨基甲酸酯)的胆汁排泄情况进行了比较。(2) 给胆管插管的大鼠注射倒千里光碱(40毫克/千克),并每隔1小时收集胆汁,吡咯代谢物的相对浓度在给药后1小时的样本中最高,给药7小时后可忽略不计。到7小时时,约25%的剂量已作为吡咯代谢物排泄。(3) 给大鼠注射[3H] Synthanecine A双-N-乙基氨基甲酸酯(40毫克/千克),胆汁中的放射性量和吡咯代谢物的相对水平在给药后0.5小时的样本中最高,给药4小时后可忽略不计。在此期间,约25%的剂量仅以[3H]放射性形式排泄到胆汁中,约5%以吡咯代谢物形式排泄。(4) 给大鼠注射[3H]2,3-双羟甲基-1-甲基吡咯(10毫克/千克),一种推测的Synthanecine A双-N-乙基氨基甲酸酯的吡咯代谢物,约17%的剂量以[3H]放射性形式排泄到胆汁中,但仅约3%可被视为吡咯代谢物。(5) 对注射[3H]2,3-双羟甲基-1-甲基吡咯或[3H] Synthanecine A双-N-乙基氨基甲酸酯的大鼠胆汁进行薄层色谱分析,结果显示几乎没有放射性或Ehrlich阳性吡咯代谢物,其RF值与2,3-双羟甲基-1-甲基吡咯的RF值相对应。大部分放射性标记和大多数Ehrlich阳性吡咯代谢物与薄层色谱板原点处的高极性衍生物相关。(6) 得出的结论是,胆汁排泄在倒千里光碱和Synthanecine A双-N-乙基氨基甲酸酯的代谢物处置中起重要作用,尽管对母体化合物不起作用。预期的羟甲基吡咯代谢物会进一步修饰为极性更强的衍生物。就倒千里光碱而言,这些衍生物仍保留与Ehrlich试剂反应的能力,而对于Synthanecine A双-N-乙基氨基甲酸酯的吡咯代谢物,则发生大量转化为Ehrlich阴性衍生物的情况。(7) 当将注射[3H] Synthanecine A双-N-乙基氨基甲酸酯的大鼠胆汁十二指肠内注射给受体动物时,放射性标记的重吸收占给予供体动物剂量的不到4%,表明肠肝循环可能仅对这些化合物的消除有次要影响。